Cargando…

Onchocerciasis: The Pre-control Association between Prevalence of Palpable Nodules and Skin Microfilariae

BACKGROUND: The prospect of eliminating onchocerciasis from Africa by mass treatment with ivermectin has been rejuvenated following recent successes in foci in Mali, Nigeria and Senegal. Elimination prospects depend strongly on local transmission conditions and therefore on pre-control infection lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coffeng, Luc E., Pion, Sébastien D. S., O'Hanlon, Simon, Cousens, Simon, Abiose, Adenike O., Fischer, Peter U., Remme, Jan H. F., Dadzie, K. Yankum, Murdoch, Michele E., de Vlas, Sake J., Basáñez, María-Gloria, Stolk, Wilma A., Boussinesq, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623701/ https://www.ncbi.nlm.nih.gov/pubmed/23593528 http://dx.doi.org/10.1371/journal.pntd.0002168

Ejemplares similares

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results
por: Tekle, Afework H., et al.
Publicado: (2016)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
por: Tekle, Afework Hailemariam, et al.
Publicado: (2012)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas
por: Niamsi-Emalio, Yannick, et al.
Publicado: (2021)

Final report of the Conference on the eradicability of Onchocerciasis
por: Dadzie, Yankum, et al.
Publicado: (2003)

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making
por: Stolk, Wilma A, et al.
Publicado: (2021)

Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa
por: O’Hanlon, Simon J., et al.
Publicado: (2016)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

The Future of Onchocerciasis Control in Africa
por: Hodgkin, Catherine, et al.
Publicado: (2007)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
por: Blok, David J, et al.
Publicado: (2020)

African Programme for Onchocerciasis Control 1995–2015: Model-Estimated Health Impact and Cost
por: Coffeng, Luc E., et al.
Publicado: (2013)

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
por: Hamley, Jonathan I D, et al.
Publicado: (2021)

The need for evidence-based strategies and tools for onchocerciasis elimination in Africa
por: Dadzie, Yankum, et al.
Publicado: (2019)

African Programme for Onchocerciasis Control 1995–2015: Updated Health Impact Estimates Based on New Disability Weights
por: Coffeng, Luc E., et al.
Publicado: (2014)

Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes
por: Dadzie, Yankum, et al.
Publicado: (2018)

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2020)

Report of the first international workshop on onchocerciasis-associated epilepsy
por: Colebunders, Robert, et al.
Publicado: (2018)

Case-control Studies on the Relationship between Onchocerciasis and Epilepsy: Systematic Review and Meta-analysis
por: Kaiser, Christoph, et al.
Publicado: (2013)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities
por: Biritwum, Nana Kwadwo, et al.
Publicado: (2019)

Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria
por: Murdoch, Michele E., et al.
Publicado: (2017)

Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study
por: Pion, Sébastien DS, et al.
Publicado: (2020)

Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal
por: Walker, Martin, et al.
Publicado: (2017)

“Test and not treat” for onchocerciasis control in a Loa loa endemic area
por: Kamgno, Joseph, et al.
Publicado: (2017)

Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon
por: Kouam, Marc K, et al.
Publicado: (2013)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness
por: Bhattacharyya, Samit, et al.
Publicado: (2023)

Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control
por: de Vlas, Sake J., et al.
Publicado: (2021)

Economic evaluations of onchocerciasis interventions: a systematic review and research needs
por: Turner, Hugo C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rdclb5fgjsgaojpuuqsfisuc8o